Allbiotech Introduces Cost-Effective Bioreactor for Precision Fermentation Research
Spanish biotech startup Allbiotech Biotechnologies has completed the first production run of its Genesys V1 bioreactor, a lower-cost alternative for precision fermentation research. The company aims to make bioreactor technology more accessible to food tech startups, research institutions, and universities by offering a system priced at one-third of the cost of traditional pharmaceutical bioreactors. With a 1-liter glass vessel, integrated sensors, and five peristaltic pumps, Genesys V1 is designed for early-stage testing, process optimization, and scale-up research in food production. Allbiotech was founded in 2024 with the goal of reducing the cost barrier associated with precision fermentation equipment. “A cost-optimized design, coupled with our experience in manufacturing high-tech equipment, has allowed us to realize a new generation of bioreactors. We are thus eliminating the economic …